Different levels of single-strain probiotic (Bacillus subtilis) with proteolytic enzyme (serratiopeptidase) can be used as an alternative to antibiotic growth promoters in broiler

• Published in: Poultry science Vol. 103; no. 3; p. 103400
• Main Authors: Mushtaq, Muhammad, Ali, Baseerat, Ali, Majid, BiBi, Neelam, Raut, Rabin, Suliman, Gamaleldin M., Swelum, Ayman A.
• Format: Journal Article
• Language: English
• Published: England Elsevier Inc 01.03.2024; Elsevier
• Subjects: Animals; Anti-Bacterial Agents; antibiotics; B. subtilis; Bacillus; Bacillus subtilis; Body Weight; body weight changes; broiler; broiler chickens; Chickens; diet; Escherichia coli; feed conversion; feed intake; growth performance; growth promotion; intestinal microorganisms; intestinal morphology; MANAGEMENT AND PRODUCTION; microbial load; Peptide Hydrolases; probiotics; Probiotics - pharmacology; production performance; proteinases; Salmonella; serratiopeptidase; small intestine; villi; B. subtilis; intestinal morphology; serratiopeptidase; production performance; broiler
• ISSN: 0032-5791; 1525-3171; 1525-3171
• DOI: 10.1016/j.psj.2023.103400

In the current study, the proteolytic enzyme (serratiopeptidase) was used to enhance the efficacy of Bacillus subtilis (B. subtilis) probiotic as a growth promotor in broiler chicken. The effects of serratiopeptidase on the efficacy of different levels of B. subtilis as a growth promotor in broiler chicks were evaluated regarding growth performance traits, villus histomorphometric characterization, and intestinal microbiota count. Day-old broiler chicks (n = 120) were allocated into 4 groups having 3 replicates/group. In the control group (C), the basal diet was kept without supplementation. In treatment groups (P100, P150, and P200), the basal diet was supplemented with 100, 150, and 200 mg probiotics, respectively besides 30 mg proteolytic enzyme in the 3 treated groups for 4 wk. The performance parameters were significantly affected by the supplementation of serratiopeptidase to the B. subtilis treatment groups. Feed intake (FI), body weight gain (WG), feed conversion ratio (FCR), and dressing percent were significantly improved in the treatment groups as compared to the control group. Significantly, the lowest feed intake was recorded for the P200 group. The highest body weight gain and dressing percentage were recorded for the P200 group. An improved FCR was recorded in the P200 group (1.7) as compared to the control group. The different levels of B. subtilis supplemented with serratiopeptidase revealed significant improvements (P<0.05) in the morphology of the intestine by showing increases in villus height and width and crypt depth of the small intestine. The microbial count revealed that E. coli and salmonella colonies were significantly reduced in the P200 group as compared to the control and other treatment groups. In conclusion, the supplementation of B. subtilis with serratiopeptidase as a growth promoter in broiler chicks significantly improved the overall performance, and intestinal health and reduced microbial load contributing to optimizing the performance of broiler chickens. The greatest improvement was observed in the P200 group fed with B. subtilis as a probiotic and serratiopeptidase enzyme (200 mg:30 mg).